![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | ISO | RGD:628652 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PCYOX1 mRNA] | CTD | PMID:31150632 | 1,2-dimethylhydrazine | decreases expression | EXP | | 6480464 | 1, 2-Dimethylhydrazine results in decreased expression of PCYOX1 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PCYOX1 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:628652 | 6480464 | Ethinyl Estradiol results in increased expression of PCYOX1 mRNA | CTD | PMID:29097150 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of PCYOX1 mRNA | CTD | PMID:21570461 | 2,6-dinitrotoluene | affects expression | ISO | RGD:628652 | 6480464 | 2, 6-dinitrotoluene affects the expression of PCYOX1 mRNA | CTD | PMID:21346803 | 3,4-methylenedioxymethamphetamine | increases expression | EXP | | 6480464 | N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of PCYOX1 mRNA | CTD | PMID:20188158 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PCYOX1 mRNA | CTD | PMID:24848799 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1350972 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PCYOX1 mRNA | CTD | PMID:28628672 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4, 4'-diaminodiphenylmethane results in increased expression of PCYOX1 mRNA | CTD | PMID:18648102 | 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of PCYOX1 mRNA | CTD | PMID:19191707 | acetamide | decreases expression | ISO | RGD:628652 | 6480464 | acetamide results in decreased expression of PCYOX1 mRNA | CTD | PMID:31881176 | afimoxifene | increases expression | ISO | RGD:1350972 | 6480464 | afimoxifene results in increased expression of PCYOX1 mRNA | CTD | PMID:16849584 | aflatoxin B1 | affects expression | ISO | RGD:1350972 | 6480464 | Aflatoxin B1 affects the expression of PCYOX1 protein | CTD | PMID:20106945 | aflatoxin B1 | decreases expression | ISO | RGD:1350972 | 6480464 | Aflatoxin B1 results in decreased expression of PCYOX1 mRNA | CTD | PMID:27153756 | ammonium chloride | affects expression | ISO | RGD:628652 | 6480464 | Ammonium Chloride affects the expression of PCYOX1 mRNA | CTD | PMID:16483693 | Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl 54% Chlorine results in decreased expression of PCYOX1 mRNA | CTD | PMID:23650126 | benzene | affects expression | ISO | RGD:628652 | 6480464 | Benzene affects the expression of PCYOX1 mRNA | CTD | PMID:15878777 | benzo[a]pyrene | affects methylation | ISO | RGD:1350972 | 6480464 | Benzoapyrene affects the methylation of PCYOX1 intron | CTD | PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | RGD:1350972 | 6480464 | Benzoapyrene results in increased methylation of PCYOX1 promoter | CTD | PMID:27901495 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RGD:1350972 | 6480464 | 7 more ... | CTD | PMID:20018196 | benzo[a]pyrene diol epoxide I | increases expression | ISO | RGD:1350972 | 6480464 | 7 more ... | CTD | PMID:20382639, PMID:26238291 | bisphenol A | increases expression | ISO | RGD:628652 | 6480464 | bisphenol A results in increased expression of PCYOX1 mRNA | CTD | PMID:25181051 more ... | bisphenol A | affects expression | ISO | RGD:1350972 | 6480464 | bisphenol A affects the expression of PCYOX1 mRNA | CTD | PMID:30903817 | bisphenol A | increases expression | ISO | RGD:1350972 | 6480464 | bisphenol A results in increased expression of PCYOX1 mRNA | CTD | PMID:29275510 | bisphenol A | multiple interactions | ISO | RGD:1350972 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PCYOX1 mRNA | CTD | PMID:28628672 | butanal | decreases expression | ISO | RGD:1350972 | 6480464 | butyraldehyde results in decreased expression of PCYOX1 mRNA | CTD | PMID:26079696 | carbon nanotube | decreases expression | EXP | | 6480464 | Nanotubes, Carbon results in decreased expression of PCYOX1 mRNA | CTD | PMID:25620056 | cisplatin | multiple interactions | ISO | RGD:1350972 | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of PCYOX1 mRNA | CTD | PMID:27392435 | copper(II) sulfate | decreases expression | ISO | RGD:1350972 | 6480464 | Copper Sulfate results in decreased expression of PCYOX1 mRNA | CTD | PMID:19549813 | crocidolite asbestos | affects expression | ISO | RGD:1350972 | 6480464 | Asbestos, Crocidolite affects the expression of PCYOX1 mRNA | CTD | PMID:17331233 | cyclosporin A | decreases expression | ISO | RGD:1350972 | 6480464 | Cyclosporine results in decreased expression of PCYOX1 mRNA | CTD | PMID:20106945 more ... | dexamethasone | multiple interactions | EXP | | 6480464 | [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PCYOX1 mRNA | CTD | PMID:24848799 | dexamethasone | multiple interactions | ISO | RGD:1350972 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PCYOX1 mRNA | CTD | PMID:28628672 | doxorubicin | decreases expression | ISO | RGD:1350972 | 6480464 | Doxorubicin results in decreased expression of PCYOX1 mRNA | CTD | PMID:29803840 | ethanol | multiple interactions | EXP | | 6480464 | Ethanol affects the expression of and affects the splicing of PCYOX1 mRNA | CTD | PMID:30319688 | flutamide | decreases expression | ISO | RGD:628652 | 6480464 | Flutamide results in decreased expression of PCYOX1 mRNA | CTD | PMID:24793618 | folic acid | multiple interactions | EXP | | 6480464 | [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of PCYOX1 mRNA | CTD | PMID:22206623 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of PCYOX1 mRNA | CTD | PMID:25629700 | gentamycin | increases expression | ISO | RGD:628652 | 6480464 | Gentamicins results in increased expression of PCYOX1 mRNA | CTD | PMID:22061828 | indometacin | multiple interactions | ISO | RGD:1350972 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of PCYOX1 mRNA | CTD | PMID:28628672 | lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of PCYOX1 mRNA | CTD | PMID:21829687 | methapyrilene | decreases expression | ISO | RGD:628652 | 6480464 | Methapyrilene results in decreased expression of PCYOX1 mRNA | CTD | PMID:30467583 | methotrexate | increases expression | ISO | RGD:1350972 | 6480464 | Methotrexate results in increased expression of PCYOX1 mRNA | CTD | PMID:17400583 | N-methyl-4-phenylpyridinium | decreases expression | EXP | | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of PCYOX1 protein | CTD | PMID:26558463 | nickel atom | decreases expression | ISO | RGD:1350972 | 6480464 | Nickel results in decreased expression of PCYOX1 mRNA | CTD | PMID:23195993 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of PCYOX1 mRNA | CTD | PMID:17562736 | paraquat | affects expression | ISO | RGD:628652 | 6480464 | Paraquat affects the expression of PCYOX1 mRNA | CTD | PMID:16854511 | perfluorononanoic acid | decreases expression | ISO | RGD:1350972 | 6480464 | perfluorononanoic acid results in decreased expression of PCYOX1 mRNA | CTD | PMID:32588087 | phenytoin | increases expression | ISO | RGD:628652 | 6480464 | Phenytoin results in increased expression of PCYOX1 mRNA | CTD | PMID:20345932 | pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of PCYOX1 mRNA | CTD | PMID:18445702 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of PCYOX1 mRNA | CTD | PMID:17426115 more ... | potassium dichromate | increases expression | ISO | RGD:1350972 | 6480464 | Potassium Dichromate results in increased expression of PCYOX1 protein | CTD | PMID:23718831 | rimonabant | multiple interactions | EXP | | 6480464 | Rimonabant inhibits the reaction [Dietary Fats results in increased expression of PCYOX1 mRNA] | CTD | PMID:19030233 | rimonabant | affects expression | EXP | | 6480464 | Rimonabant affects the expression of PCYOX1 mRNA | CTD | PMID:19030233 | silicon dioxide | decreases expression | EXP | | 6480464 | Silicon Dioxide results in decreased expression of PCYOX1 mRNA | CTD | PMID:19073995 | silicon dioxide | increases expression | EXP | | 6480464 | Silicon Dioxide results in increased expression of PCYOX1 mRNA | CTD | PMID:23221170 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of PCYOX1 protein | CTD | PMID:29044176 | tert-butyl hydroperoxide | decreases expression | ISO | RGD:1350972 | 6480464 | tert-Butylhydroperoxide results in decreased expression of PCYOX1 mRNA | CTD | PMID:15336504 | testosterone enanthate | affects expression | ISO | RGD:1350972 | 6480464 | testosterone enanthate affects the expression of PCYOX1 mRNA | CTD | PMID:17440010 | tetrachloromethane | multiple interactions | ISO | RGD:628652 | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of PCYOX1 mRNA] | CTD | PMID:31150632 | tetrachloromethane | decreases expression | EXP | | 6480464 | Carbon Tetrachloride results in decreased expression of PCYOX1 mRNA | CTD | PMID:31919559 | tetrachloromethane | decreases expression | ISO | RGD:628652 | 6480464 | Carbon Tetrachloride results in decreased expression of PCYOX1 mRNA | CTD | PMID:31150632 | titanium dioxide | increases expression | EXP | | 6480464 | titanium dioxide results in increased expression of PCYOX1 mRNA | CTD | PMID:23409001 | tributylstannane | increases expression | EXP | | 6480464 | tributyltin results in increased expression of PCYOX1 mRNA | CTD | PMID:24848799 | trichostatin A | affects expression | ISO | RGD:1350972 | 6480464 | trichostatin A affects the expression of PCYOX1 mRNA | CTD | PMID:28542535 | triphenyl phosphate | affects expression | ISO | RGD:628652 | 6480464 | triphenyl phosphate affects the expression of PCYOX1 mRNA | CTD | PMID:30589522 | valproic acid | increases expression | ISO | RGD:1350972 | 6480464 | Valproic Acid results in increased expression of PCYOX1 mRNA | CTD | PMID:19101580 | valproic acid | affects expression | ISO | RGD:1350972 | 6480464 | Valproic Acid affects the expression of PCYOX1 mRNA | CTD | PMID:25979313 | zinc atom | increases expression | ISO | RGD:1350972 | 6480464 | Zinc deficiency results in increased expression of PCYOX1 mRNA | CTD | PMID:22171008 | zinc(0) | increases expression | ISO | RGD:1350972 | 6480464 | Zinc deficiency results in increased expression of PCYOX1 mRNA | CTD | PMID:22171008 | zoledronic acid | increases expression | ISO | RGD:1350972 | 6480464 | zoledronic acid results in increased expression of PCYOX1 mRNA | CTD | PMID:20977926 | |